This approach allowed us to test the hypothesis that glucose metabolism-related genetic variants are associated with increased risk of cancers and that the relationships depend on impaired glucose metabolism symptoms (high insulin, glucose, and HOMA-IR levels). The gene discussed is INS; the disease is cancer.